Differential impact of cysteine cathepsins on genetic mouse models of de novo carcinogenesis: cathepsin B as emerging therapeutic target

Reinheckel, Thomas; Peters, Christoph; Krüger, Achim; Turk, Boris; Vasiljeva, Olga
July 2012
Frontiers in Pharmacology;Jul2012, Vol. 3, p1
Academic Journal
No abstract available.


Related Articles

  • Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis. Allan, Euan Ramsay Orr; Yates, Robin Michael // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    The cysteine cathepsins B, S, and L are functionally linked to antigen processing, and hence to autoimmune disorders such as multiple sclerosis. Stemming from several studies that demonstrate that mice can be protected from experimental autoimmune encephalomyelitis (EAE) through the...

  • The importance of cysteine cathepsin proteases for placental development. Varanou, Aikaterini; Withington, Sarah L.; Lakasing, Lorin; Williamson, Catherine; Burton, Graham J.; Hemberger, Myriam // Journal of Molecular Medicine;Apr2006, Vol. 84 Issue 4, p305 

    The typically lysosomal family of cysteine cathepsin proteases has been implicated in the development of the placenta in particular, from studies in the mouse. Here, we analysed overall expression, regulation and presence of transcript isoforms of cysteine cathepsins during human extra-embryonic...

  • Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice. Gopinathan, Aarthi; DeNicola, Gina M.; Frese, Kristopher K.; Cook, Natalie; Karreth, Florian A.; Mayerle, Julia; Lerch, Markus M.; Reinheckel, Thomas; Tuveson, David A. // Gut;Jun2012, Vol. 61 Issue 6, p877 

    Objective The lysosomal protease cathepsin B is upregulated in human pancreatic ductal adenocarcinoma (PDA) and represents a potential therapeutic target. Loss of cathepsin B delays tumour progression in mouse models of islet, mammary and intestinal carcinoma and decreases invasion and...

  • Deficiency for the Cysteine Protease Cathepsin L Impairs Myc-Induced Tumorigenesis in a Mouse Model of Pancreatic Neuroendocrine Cancer. Brindle, Nicola R.; Joyce, Johanna A.; Rostker, Fanya; Lawlor, Elizabeth R.; Swigart-Brown, Lamorna; Evan, Gerard; Hanahan, Douglas; Shchors, Ksenya // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Motivated by the recent implication of cysteine protease cathepsin L as a potential target for anti-cancer drug development, we used a conditional MycERTAM;Bcl-xL model of pancreatic neuroendocrine tumorigenesis (PNET) to assess the role of cathepsin L in Myc-induced tumor progression. By...

  • Cathepsin L increases invasion and migration of B16 melanoma. Zhen Yang; Cox, James L. // Cancer Cell International;2007, Vol. 7, p8 

    Background: Most cancers express elevated protease levels which contribute to certain aspects of tumor behavior such as growth, metastatic spread, and angiogenesis. Elevation of the cathepsins of the cysteine protease family correlates with increased invasion of tumor cells. Cysteine proteases...

  • Cytoskeletal architecture and cathepsin B trafficking in human articular chondrocytes. Zwicky, Roman; Baici, Antonio // Histochemistry & Cell Biology;Nov2000, Vol. 114 Issue 5, p363 

    In the differentiated state, human articular chondrocytes exhibited modestly developed cytoskeletal components, while cells dedifferentiated by serial subcultures in vitro displayed a prominent cytoskeleton. Morphological changes, a well-developed actin cytoskeleton, and the presence of numerous...

  • Cathepsin Gene Family Reveals Transcriptome Patterns Related to the Infective Stages of the Salmon Louse Caligus rogercresseyi. Maldonado-Aguayo, Waleska; Chávez-Mardones, Jacqueline; Gonçalves, Ana Teresa; Gallardo-Escárate, Cristian // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Cathepsins are proteases involved in the ability of parasites to overcome and/or modulate host defenses so as to complete their own lifecycle. However, the mechanisms underlying this ability of cathepsins are still poorly understood. One excellent model for identifying and exploring the...

  • Thiol-Dependent Cathepsins: Pathophysiological Implications and Recent Advances in Inhibitor Design. D. Bromme; J. Kaleta // Current Pharmaceutical Design;Aug2002, Vol. 8 Issue 18, p1639 

    Thirteen papain-like cysteine proteases (cathepsins) are coded in the human genome from which two represent pseudogenes. Initially it was believed that lysosomal cysteine proteases primarily fulfill house-keeping functions which would exclude them as potential drug targets. Within the last...

  • Non-Covalent Cathepsin K Inhibitors for the Treatment of Osteoporosis. Tae-Seong Kim; Tasker, Andrew S. // Current Topics in Medicinal Chemistry;Feb2006, Vol. 6 Issue 4, p355 

    Cathepsin K is a cysteine protease that plays an important role in the pathological process of bone resorption. Selective cathepsin K inhibitors may thus provide great potential in the treatment of osteoporosis. Pharmaceutical interest in this area is highlighted by the rising number of...

  • Cathepsin B is a New Drug Target for Traumatic Brain injury Therapeutics: evidence for e64d as a Promising Lead Drug Candidate. Hook, Gregory; Jacobsen, J. Steven; Grabstein, Kenneth; Kindy, Mark; Hook, Vivian; Hånell, Anders; Anagli, John // Frontiers in Neurology;Sep2015, p1 

    There is currently no therapeutic drug treatment for traumatic brain injury (TBI) despite decades of experimental clinical trials. This may be because the mechanistic pathways for improving TBI outcomes have yet to be identified and exploited. As such, there remains a need to seek out new...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics